Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mangoceuticals (MGRX) Assets Average (2023 - 2025)

Mangoceuticals (MGRX) has disclosed Assets Average for 3 consecutive years, with $16.3 million as the latest value for Q4 2025.

  • Quarterly Assets Average rose 8.15% to $16.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.3 million through Dec 2025, up 8.15% year-over-year, with the annual reading at $15.7 million for FY2025, 91.58% up from the prior year.
  • Assets Average hit $16.3 million in Q4 2025 for Mangoceuticals, down from $18.7 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $21.3 million in Q2 2025 to a low of $676120.0 in Q1 2024.
  • Historically, Assets Average has averaged $11.0 million across 3 years, with a median of $15.0 million in 2024.
  • Biggest YoY gain for Assets Average was 2645.4% in 2025; the steepest drop was 8.15% in 2025.
  • Year by year, Assets Average stood at $1.3 million in 2023, then surged by 1039.8% to $15.1 million in 2024, then grew by 8.15% to $16.3 million in 2025.
  • Business Quant data shows Assets Average for MGRX at $16.3 million in Q4 2025, $18.7 million in Q3 2025, and $21.3 million in Q2 2025.